Article Text
Abstract
Institutional review boards (IRB) normally require of a morally defensible clinical trial that any trial participant will benefit from the inquiry, or at least not be exposed to a significant risk of having their prospects worsened by participating. Stage 1 HIV cure trials tend not to meet this requirement. Does that show them to be morally indefensible? Utilitarian thinking about this question supports a negative answer. But one might reasonably expect a Kantian moral theory to support the conclusion that exposing trial participants to a significant risk of their prospects being worsened by their participation to be morally indefensible, on grounds that this would be a clear case of using a person as a mere means. In this paper, I argue, drawing on Kantian contractualist thinking, that requiring the risk/benefit ratio for participants be positive if a trial is to be morally defensible does not in fact gain any support from Kantian thinking about morality.
- Research Ethics
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Funding National Institute of Allergy and Infectious Diseases (grant no. 1 R01 AI114617-01A1; 1 R56 AI114617-01).
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.
Other content recommended for you
- The morality of risks in research: reflections on Kumar
- Challenge studies of human volunteers: ethical issues
- Ethical guidelines for deliberately infecting volunteers with COVID-19
- How to keep high-risk studies ethical: classifying candidate solutions
- When should conscientious objection be accepted?
- Intuitions, principles and consequences
- Moral dimensions
- The unwitting sacrifice problem
- A randomised controlled trial of ribavirin in Crimean Congo haemorrhagic fever: ethical considerations
- Good parents would not fulfil their obligation to genetically enhance their unborn children